{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:54:39Z","timestamp":1787943279248,"version":"build-2784847793"},"reference-count":63,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.trecan.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T07:23:31Z","timestamp":1537428211000},"page":"718-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes"],"prefix":"10.1016","volume":"4","author":[{"given":"Julia","family":"Taeubner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layal","family":"Yasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triantafyllia","family":"Brozou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Borkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4577-0503","authenticated-orcid":false,"given":"Michaela","family":"Kuhlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2018.09.002_bib0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00431-015-2565-x","article-title":"Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing","volume":"174","author":"Kuhlen","year":"2015","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.trecan.2018.09.002_bib0010","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/gim.2014.191","article-title":"Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios","volume":"17","author":"Zhu","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.trecan.2018.09.002_bib0015","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2018.09.002_bib0020","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1158\/2159-8290.CD-15-0892","article-title":"Infection exposure is a causal factor in B-cell precursor acute lymphoblastic leukemia as a result of Pax5-inherited susceptibility","volume":"5","author":"Martin-Lorenzo","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2018.09.002_bib0025","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(16)30147-4","article-title":"Monogenic and polygenic determinants of sarcoma risk: an international genetic study","volume":"17","author":"Ballinger","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2018.09.002_bib0030","article-title":"Germline determinants of the somatic mutation landscape in 2,642 cancer genomes","author":"Waszak","year":"2017","journal-title":"bioRxiv"},{"key":"10.1016\/j.trecan.2018.09.002_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00431-017-2997-6","article-title":"Genetic predisposition in children with cancer \u2013 affected families\u2019 acceptance of Trio-WES","volume":"177","author":"Brozou","year":"2018","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.trecan.2018.09.002_bib0040","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2018.09.002_bib0045","first-page":"106","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis","author":"Friebel","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.trecan.2018.09.002_bib0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10689-013-9614-2","article-title":"Genetic modifiers of cancer risk in Lynch syndrome: a review","volume":"12","author":"Talseth-Palmer","year":"2013","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.trecan.2018.09.002_bib0055","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.tig.2013.04.005","article-title":"Properties and rates of germline mutations in humans","volume":"29","author":"Campbell","year":"2013","journal-title":"Trends Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0060","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1158\/1078-0432.CCR-17-0834","article-title":"Genetic counselor recommendations for cancer predisposition evaluation and surveillance in the pediatric oncology patient","volume":"23","author":"Druker","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2018.09.002_bib0065","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1200\/JCO.2009.25.7816","article-title":"Genome-wide association studies of cancer","volume":"28","author":"Stadler","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2018.09.002_bib0070","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/aje\/kwq234","article-title":"Genome-wide significant associations for variants with minor allele frequency of 5% or less\u2013an overview: a HuGE review","volume":"172","author":"Panagiotou","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.trecan.2018.09.002_bib0075","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1093\/hmg\/ddn287","article-title":"Genome-wide association studies in cancer","volume":"17","author":"Easton","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0080","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/carcin\/bgr056","article-title":"Genetic architecture of cancer and other complex diseases: lessons learned and future directions","volume":"32","author":"Hindorff","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.trecan.2018.09.002_bib0085","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1200\/JCO.2014.58.2569","article-title":"Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations","volume":"32","author":"Smith","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2018.09.002_bib0090","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1073\/pnas.89.13.6177","article-title":"Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype","volume":"89","author":"Onadim","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2018.09.002_bib0095","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1158\/1078-0432.CCR-17-0652","article-title":"Retinoblastoma and neuroblastoma predisposition and surveillance","volume":"23","author":"Kamihara","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2018.09.002_bib0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","article-title":"Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome","volume":"30","author":"Amadou","year":"2018","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.trecan.2018.09.002_bib0105","first-page":"67","article-title":"Genetic causes of cancer predisposition in children and adolescents","volume":"4","author":"Saletta","year":"2015","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.trecan.2018.09.002_bib0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2220\/biomedres.37.259","article-title":"Prevalence of low-penetrant germline TP53 D49H mutation in Japanese cancer patients","volume":"37","author":"Yamaguchi","year":"2016","journal-title":"Biomed. Res."},{"key":"10.1016\/j.trecan.2018.09.002_bib0115","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/onc.2009.194","article-title":"Genetic predisposition to human disease: allele-specific expression and low-penetrance regulatory loci","volume":"28","author":"de la Chapelle","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2018.09.002_bib0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejmhg.2014.01.003","article-title":"Reduced penetrance in human inherited disease","volume":"15","author":"Shawky","year":"2014","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000480","article-title":"Polymorphic cis- and trans-regulation of human gene expression","volume":"8","author":"Cheung","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.trecan.2018.09.002_bib0130","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00439-013-1331-2","article-title":"Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease","volume":"132","author":"Cooper","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0135","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1086\/512017","article-title":"Gene-expression variation within and among human populations","volume":"80","author":"Storey","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0140","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.1073\/pnas.0802970105","article-title":"Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome","volume":"105","author":"Shlien","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2018.09.002_bib0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/mgme.2000.3052","article-title":"Modifier genes convert \u201csimple\u201d Mendelian disorders to complex traits","volume":"71","author":"Dipple","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.trecan.2018.09.002_bib0150","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cell.2004.11.022","article-title":"A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans","volume":"119","author":"Bond","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2018.09.002_bib0155","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.onc.1207305","article-title":"A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA","volume":"23","author":"Gemignani","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2018.09.002_bib0160","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/carcin\/bgt381","article-title":"Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures","volume":"35","author":"Sagne","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.trecan.2018.09.002_bib0165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","article-title":"Neurofibromatosis type 1: from genotype to phenotype","volume":"49","author":"Pasmant","year":"2012","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41431-017-0048-4","article-title":"Congenital embryonal rhabdomyosarcoma caused by heterozygous concomitant PTCH1 and PTCH2 germline mutations","volume":"26","author":"Taeubner","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0175","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708641","article-title":"Trio sequencing in pediatric cancer and clinical implications","volume":"10","author":"Kuhlen","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.trecan.2018.09.002_bib0180","doi-asserted-by":"crossref","first-page":"D900","DOI":"10.1093\/nar\/gkv1068","article-title":"DIDA: a curated and annotated digenic diseases database","volume":"44","author":"Gazzo","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.trecan.2018.09.002_bib0185","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1093\/nar\/gkx557","article-title":"Understanding mutational effects in digenic diseases","volume":"45","author":"Gazzo","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.trecan.2018.09.002_bib0190","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jcp.2008.062646","article-title":"Age-dependent penetrance of different germline mutations in the BRCA1 gene","volume":"62","author":"Al-Mulla","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.trecan.2018.09.002_bib0195","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0200","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10654-015-0089-3","article-title":"Risk for childhood leukemia associated with maternal and paternal age","volume":"30","author":"Sergentanis","year":"2015","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.trecan.2018.09.002_bib0205","first-page":"1932","article-title":"P53 germline mutations in childhood cancers and cancer risk for carrier individuals","volume":"82","author":"Chompret","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2018.09.002_bib0210","first-page":"246","article-title":"Role of epigenetics in biology and human diseases","volume":"20","author":"Moosavi","year":"2016","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.trecan.2018.09.002_bib0215","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798783","article-title":"Lmo2 expression defines tumor cell identity during T-cell leukemogenesis","volume":"37","author":"Garcia-Ramirez","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.trecan.2018.09.002_bib0220","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.trecan.2018.04.007","article-title":"Epigenetic priming in cancer initiation","volume":"4","author":"Vicente-Duenas","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2018.09.002_bib0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4161\/epi.7.1.18814","article-title":"Monozygotic twins discordant for constitutive BRCA1 promoter methylation, childhood cancer and secondary cancer","volume":"7","author":"Galetzka","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.trecan.2018.09.002_bib0230","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/bies.20522","article-title":"Non-genomic transgenerational inheritance of disease risk","volume":"29","author":"Gluckman","year":"2007","journal-title":"BioEssays"},{"key":"10.1016\/j.trecan.2018.09.002_bib0235","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1471-0528.2008.01822.x","article-title":"Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life","volume":"115","author":"Painter","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.trecan.2018.09.002_bib0240","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1158\/0008-5472.CAN-11-4067","article-title":"Characterization of gene-environment interactions for colorectal cancer susceptibility loci","volume":"72","author":"Hutter","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2018.09.002_bib0245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00439-012-1239-2","article-title":"Genome-wide investigation of gene-environment interactions in colorectal cancer","volume":"132","author":"Siegert","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0250","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/bcr1630","article-title":"Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers","volume":"8","author":"Antoniou","year":"2006","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.trecan.2018.09.002_bib0255","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","article-title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"8","author":"McLaughlin","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2018.09.002_bib0260","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/ng.109","article-title":"Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1","volume":"40","author":"Amos","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0265","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1470-2045(10)70126-1","article-title":"Genetics of lung-cancer susceptibility","volume":"12","author":"Brennan","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2018.09.002_bib0270","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/cam4.538","article-title":"Early-life exposures to infectious agents and later cancer development","volume":"4","author":"Vedham","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.trecan.2018.09.002_bib0275","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nrc3610","article-title":"The microbiome and cancer","volume":"13","author":"Schwabe","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2018.09.002_bib0280","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1158\/1940-6207.CAPR-15-0406","article-title":"Transforming cancer prevention through precision medicine and immune-oncology","volume":"9","author":"Kensler","year":"2016","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.trecan.2018.09.002_bib0285","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/ng.3425","article-title":"Standardized phenotyping enhances Mendelian disease gene identification","volume":"47","author":"Vissers","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0290","doi-asserted-by":"crossref","first-page":"D966","DOI":"10.1093\/nar\/gkt1026","article-title":"The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data","volume":"42","author":"Kohler","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.trecan.2018.09.002_bib0295","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/ijc.30907","article-title":"The prevalence of DICER1 pathogenic variation in population databases","volume":"141","author":"Kim","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.trecan.2018.09.002_bib0300","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1038\/sj.onc.1207714","article-title":"Highly penetrant hereditary cancer syndromes","volume":"23","author":"Nagy","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2018.09.002_bib0305","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.trecan.2018.09.002_bib0310","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/nar\/gku1094","article-title":"Mechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions","volume":"43","author":"Betts","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.trecan.2018.09.002_bib0315","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/gtmb.2010.0036","article-title":"Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations","volume":"14","author":"Flanagan","year":"2010","journal-title":"Genet. Test. Mol. Biomarkers"}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240580331830195X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240580331830195X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:48:06Z","timestamp":1762505286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240580331830195X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S240580331830195X"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2018.09.002","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}